TABLE 1.
The applications of novel polymeric nanoagents in cancer diagnosis.
| Types | Conjugation | Imaging techniques | Indications | Advantages | Ref |
|---|---|---|---|---|---|
| Fol-cht-based polymer | Technetium-99m | SPECT/CT | Folate receptor-overexpressed cancers | Targeting to folate receptor-overexpressed cancer cells | Polyak et al. (2014) |
| Fol-cht-based polymer | Magnetic PLGA | MRI | Oral cancer cells | Providing SPIONs delivery, further shortening T2 relaxation time and enhancing nanoparticle relaxivity | Shanavas et al. (2017) |
| Fol-cht-based polymer | 5-ALA | Performing 5-ALA-based PDD | Oral cancer, CIN, prostate cancer, glioblastoma | Increasing the uptake of 5-ALA, the accumulation of PpIX fluorescence and facilitating the photodynamic detection | Yang et al. (2013); Babic et al. (2018); Casas, (2020); Xu et al. (2021) |
| SPNs | TPP | NIR | Various cancers | Producing shifted NIR luminescence, allowing the in vivo tiny cancer imaging via sensing low oxygen | Cui et al. (2018) |
| SPNs | AF | PA | Various cancers | Generating stronger PA signal and improving photodiagnostic efficacy | Li et al. (2018) |
| SPNs | RBC | PA | Various cancers | Enhancing NIR light absorption and photostability | Zheng et al. (2020) |
| HA | ICG | NIR | Prostate cancer | Augmenting optical stability and reducing systemic toxicity | Souchek et al. (2018) |
| BSA | ICG | NIR-I | Cervical cancer, neuroblastoma | Producing strong NIR-I fluorescence emission | Ma et al. (2021); Clutter et al. (2022) |
| PSMA | ICG | NIR | Cervical cancer | Improving the chemical stability and biocompatibility | Chen et al. (2021) |
| PLGA | ICG | NIR | Cervical cancer | Enhancing the NIR stability and internalization, reducing cytotoxicity | Choi et al. (2021) |
| PEG | ICG | NIR | Various cancers | Showing more sensitive imaging and strong targeting ability | Wang et al. (2022b) |
| PNMs | ICG | NIR | Various cancers | Inhibiting ICG leakage and indicating favorable biocompatibility | Hsu et al. (2020) |
| PAH | ICG | NIR | Ovarian cancer | Enhancing the fluorescence stability and targeting ability | Bahmani et al. (2014) |
| PCL | ICG | NIR, X-ray | Various cancers | Boosting the fluorescence stability, and having minimized adverse effects on the surrounding tissues | Gorecka et al. (2022) |